Intellectual Property India Publishes Patent Application for 'Novel Triple Activator Having Activity On All Of Glp 1 Gip And Glucagon Receptors And Pharmaceutical Composition For Preventing Or Treating Obesity Comprising Same' Filed by Hanmi Pharm. Co. Ltd.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202527069269 A) filed by Hanmi Pharm. Co. Ltd., Gyeonggi, Republic of Korea, on July 21, for 'novel triple activator having activity on all of glp 1 gip and glucagon receptors and pharmaceutical composition for preventing or treating obesity comprising same.'

Inventor(s) include Kim Yo Han; Kim Jung Kuk; Shin Min Kyung; and Im Hyeon Joo.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a novel trigonal agonist having activity on all of GLP 1 GIP and glucagon receptors and uses thereof in the prevention or treatment of obesity."

The patent application was internationally filed on Dec. 22, 2023, under International application No.PCT/KR2023/021392.

Disclaimer: Curated by HT Syndication.